4.3 Review

Steroid resistance in asthma: Mechanisms and treatment options

期刊

CURRENT ALLERGY AND ASTHMA REPORTS
卷 8, 期 2, 页码 171-178

出版社

CURRENT SCIENCE INC
DOI: 10.1007/s11882-008-0028-4

关键词

-

资金

  1. Medical Research Council [G0400503B] Funding Source: researchfish

向作者/读者索取更多资源

Glucocorticoid insensitivity presents a profound management problem in patients with asthma because conventional therapies are not effective. Glucocorticoids, acting through the glucocorticoid receptor (GR), are able to selectively repress inflammatory gene expression by utilizing several distinct mechanisms targeting nuclear factor-kappa B and activator protein-1 activation complexes and by effects on mitogen-activated protein kinases. Different model systems often activate distinct sets of signaling molecules and different glucocorticoid responsiveness may result from differences in concentrations and timing of steroid treatment of cells, GR expression levels, and the precise inflammatory stimulus used. Thus, abnormal activation of many signaling pathways may affect corticosteroid responsiveness in patients with corticosteroid-resistant asthma. Understanding the molecular mechanisms of GR action and inaction may lead to the development of new anti-inflammatory drugs or enable clinicians to reverse the relative steroid-insensitivity that is characteristic of some patients with severe asthma.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Allergy

IL1RAP expression and the enrichment of IL-33 activation signatures in severe neutrophilic asthma

Yusef Eamon Badi, Barbora Salcman, Adam Taylor, Batika Rana, Nazanin Zounemat Kermani, John H. Riley, Sally Worsley, Sharon Mumby, Sven-Eric Dahlen, David Cousins, Bulfone-Paus Silvia, Karen Affleck, Kian Fan Chung, Stewart Bates, Ian M. Adcock

Summary: IL-33-activated gene signatures are elevated in neutrophilic and mixed granulocytic asthma corresponding with IL1RAP co-receptor expression. This suggests incorporating T2-low asthma in anti-IL-33 trials.

ALLERGY (2023)

Review Respiratory System

Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA)

Ekaterina Khaleva, Anna Rattu, Chris Brightling, Andrew Bush, Apostolos Bossios, Arnaud Bourdin, Kian Fan Chung, Rekha Chaudhuri, Courtney Coleman, Sven-Erik Dahlen, Ratko Djukanovic, Antoine Deschildre, Louise Fleming, Stephen J. Fowler, Atul Gupta, Eckard Hamelmann, Simone Hashimoto, Gunilla Hedlin, Gerard H. Koppelman, Erik Melen, Clare S. Murray, Charles Pilette, Celeste Porsbjerg, Katharine C. Pike, Franca Rusconi, Clare Williams, Birgit Ahrens, Peter Alter, Freja Anckers, Maarten van den Berge, Katharina Blumchen, Guy Brusselle, Graham W. Clarke, Danen Cunoosamy, Barbro Dahlen, Piers Dixey, Andrew Exley, Urs Frey, Erol A. Gaillard, Lisa Giovannini-Chami, Jonathan Grigg, Diana Hartenstein, Liam G. Heaney, Bulent Karadag, Susanne Kaul, Inger Kull, Amelia Licari, Anke H. Maitland-van der Zee, Vera Mahler, Ann-Marie M. Schoos, Prasad Nagakumar, Jenny Negus, Hanna Nielsen, James Paton, Marielle Pijnenburg, Valeria Ramiconi, Sofia Romagosa Vilarnau, Stefania Principe, Niels Rutjes, Sejal Saglani, Paul Seddon, Florian Singer, Heribert Staudinger, Steve Turner, Susanne Vijverberg, Tonya Winders, Valentyna Yasinska, Graham Roberts

Summary: The COMSA Working Group developed two Core Outcome Measures (COM) sets for paediatric and adult severe asthma, including FEV1 as z-scores, frequency of severe exacerbations and oral corticosteroid use. These COM sets will inform future clinical trials, enhance comparability of biological therapies' efficacy and effectiveness, and assess their socioeconomic value.

EUROPEAN RESPIRATORY JOURNAL (2023)

Article Environmental Sciences

Characteristics of fine and ultrafine aerosols in the London underground

Prashant Kumar, Juan C. Zavala-Reyes, Gopinath Kalaiarasan, Hisham Abubakar-Waziri, Gloria Young, Ian Mudway, Claire Dilliway, Ramzi Lakhdar, Sharon Mumby, Michal M. Klosowski, Christopher C. Pain, Ian M. Adcock, Jonathan S. Watson, Mark A. Sephton, Kian Fan Chung, Alexandra E. Porter

Summary: The study examined the distribution characteristics of ultrafine particles in a London underground platform, finding that particle number concentrations gradually increased and reached a peak between 18:00 and 21:00. Harmful organic compounds and metal mixtures were also identified, highlighting the need for improved ventilation conditions in underground railway systems.

SCIENCE OF THE TOTAL ENVIRONMENT (2023)

Article Respiratory System

Th2 high and mast cell gene signatures are associated with corticosteroid sensitivity in COPD

Alen Faiz, Stelios Pavlidis, Chih-Hsi Kuo, Anthony Rowe, Pieter S. Hiemstra, Wim Timens, Marijn Berg, Marissa Wisman, Yi-Ke Guo, Ratko Djukanovi, Peter Sterk, Kerstin B. Meyer, Martijn C. Nawijn, Ian Adcock, Kian Fan Chung, Maarten van den Berge

Summary: By analyzing the gene expression signatures in bronchial biopsies, we found that severe asthma and COPD share common characteristics such as relative corticosteroid insensitivity. Among COPD patients receiving inhaled corticosteroids, we identified a subgroup of patients with a TAC1 signature that was responsive to treatment, while the other two signatures (TAC2 and TAC3) were not affected. The presence of the TAC1 signature in bronchial biopsies was associated with corticosteroid responsiveness. This study has significant implications for personalized treatment decisions and outcome prediction in airway diseases.

THORAX (2023)

Article Respiratory System

Macrophage migration inhibitory factor promotes glucocorticoid resistance of neutrophilic inflammation in a murine model of severe asthma

Venkata Sita Rama Raju Allam, Stelios Pavlidis, Gang Liu, Nazanin Zounemat Kermani, Jennifer Simpson, Joyce To, Sheila Donnelly, Yi-Ke Guo, Philip M. Hansbro, Simon Phipps, Eric F. Morand, Ratko Djukanovic, Peter Sterk, Kian Fan Chung, Ian Adcock, James Harris, Maria B. Sukkar

Summary: The study showed that MIF protein correlates with clinical and molecular features of severe neutrophilic asthma and reduces the biological activity of annexin-A1 through interaction, promoting glucocorticoid resistance of neutrophilic inflammation.

THORAX (2023)

Article Pharmacology & Pharmacy

Elevated serum polyclonal immunoglobulin free light chains in patients with severe asthma

Umberto Basile, Giuseppe Santini, Cecilia Napodano, Giuseppe Macis, Krizia Pocino, Francesca Gulli, Mario Malerba, Andrew Bush, Ian M. Adcock, Paolo Montuschi

Summary: This study found that serum Ig FLC concentrations were elevated in adult males with severe asthma, and these concentrations were correlated with inflammatory outcomes. These findings suggest that serum Ig FLCs could serve as potential surrogate markers of inflammation in asthma.

FRONTIERS IN PHARMACOLOGY (2023)

Article Respiratory System

Changes in targeted metabolomics in lung tissue of chronic obstructive pulmonary disease

Yi Feng, Meiqin Xie, Qi Liu, Jiali Weng, Liangyu Wei, Kian Fan Chung, Ian M. Adcock, Qing Chang, Mengnan Li, Yan Huang, Hai Zhang, Feng Li

Summary: In this study, targeted metabolomics analysis was performed on lung tissue samples from COPD patients and mouse models. The expression of many metabolites was found to be altered in both COPD patients and mice, indicating the potential involvement of amino acid metabolism, energy production pathway, and lipid metabolism in the pathogenesis of COPD.

JOURNAL OF THORACIC DISEASE (2023)

Article Respiratory System

Precision Medicine Intervention in Severe Asthma (PRISM) study: molecular phenotyping of patients with severe asthma and response to biologics

Ji-Hyang Lee, Piers Dixey, Pank Bhavsar, Katie Raby, Nazanin Kermani, Marc Chadeau-Hyam, Ian M. Adcock, Woo-Jung Song, Hyouk-Soo Kwon, Sei-Won Lee, You Sook Cho, Kian Fan Chung, Tae-Bum Kim

Summary: The Precision Medicine Intervention in Severe Asthma (PRISM) project aims to identify molecular phenotypes of severe asthma by analyzing multi-omics data. Clinical information and biological samples will be collected, and follow-up evaluations will be conducted to assess phenotype stability and treatment responses. Through data analysis, molecular pathways driving lung function, asthma control, exacerbations, and therapeutic response to biologics will be identified.

ERJ OPEN RESEARCH (2023)

Editorial Material Critical Care Medicine

CC16: A Treatable Trait in Asthma?

Chloe I. Bloom, Ian M. Adcock

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Article Critical Care Medicine

IL-33 Expression Is Lower in Current Smokers at both Transcriptomic and Protein Levels

Alen Faiz, Rashad M. Mahbub, Fia Sabrina Boedijono, Milan I. Tomassen, Wierd Kooistra, Wim Timens, Martijn Nawijn, Philip M. Hansbro, Matt D. Johansen, Simon D. Pouwels, Irene H. Heijink, Florian Massip, Maria Stella de Biase, Roland F. Schwarz, Ian M. Adcock, Kian F. Chung, Anne van der Does, Pieter S. Hiemstra, Helene Goulaouic, Heming Xing, Raolat Abdulai, Emanuele de Rinaldis, Danen Cunoosamy, Sivan Harel, David Lederer, Michael C. Nivens, Peter A. Wark, Huib A. M. Kerstjens, Machteld N. Hylkema, Corry-Anke Brandsma, Maarten van den Berge

Summary: Smoking leads to a decrease in IL-33 expression at the gene and protein level, possibly due to a reduction in resting basal cells. These findings may explain why anti-IL-33 treatment is more effective in former smokers with COPD.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Article Biochemistry & Molecular Biology

Does Chronic Obstructive Pulmonary Disease Originate from Different Cell Types?

Yohannes Tesfaigzi, Jeffrey L. Curtis, Irina Petrache, Francesca Polverino, Farrah Kheradmand, Ian M. Adcock, Stephen I. Rennard

Summary: The onset of chronic obstructive pulmonary disease (COPD) is heterogeneous, and current approaches to define distinct disease phenotypes are lacking. This perspective discusses the role of different cell types in COPD pathogenesis and the application of new technologies in understanding the pathophysiology and clinical heterogeneity of COPD.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2023)

Article Biochemistry & Molecular Biology

Possible cancer-causing capacity of COVID-19: Is SARS-CoV-2 an oncogenic agent?

Kasra Jahankhani, Fatemeh Ahangari, Ian M. Adcock, Esmaeil Mortaz

Summary: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has short-term and long-term effects, with potential to cause cancer in different organs through various strategies. These strategies include manipulation of the renin angiotensin system, alteration of tumor suppressing pathways, and triggering of inflammatory cascades. Infection with SARS-CoV-2 can lead to the development of cancer stem cells in multiple organs. However, long-term consequences of this virus and its proteins in cancer development will only be revealed over time.

BIOCHIMIE (2023)

Article Immunology

The role of inflammation in anxiety and depression in the European U-BIOPRED asthma cohorts

Ruihua Hou, Gang Ye, Xiaojing Cheng, Dominick E. Shaw, Per S. Bakke, Massimo Caruso, Barbro Dahlen, Sven-Erik Dahlen, Stephen J. Fowler, Ildiko Horvath, Peter Howarth, Norbert Krug, Paolo Montuschi, Marek Sanak, Thomas Sandstrom, Charles Auffray, Bertrand De Meulder, Ana R. Sousa, Ian M. Adcock, Kian Fan Chung, Peter J. Sterk, Paul J. Skipp, James Schofield, Ratko Djukanovic

Summary: This study investigated the role of inflammation in comorbid anxiety and depression in asthma patients and found that severe asthma patients have higher levels of anxiety and depression, which may be associated with inflammatory responses.

BRAIN BEHAVIOR AND IMMUNITY (2023)

Article Immunology

Expression of targets of the RNA-binding protein AUF-1 in human airway epithelium indicates its role in cellular senescence and inflammation

Ilaria Salvato, Luca Ricciardi, Jessica Dal Col, Annunziata Nigro, Giorgio Giurato, Domenico Memoli, Assunta Sellitto, Erwin Pavel Lamparelli, Maria Assunta Crescenzi, Monica Vitale, Alessandro Vatrella, Francesco Nucera, Paola Brun, Federico Caicci, Paola Dama, Thomas Stiff, Leandro Castellano, Sobia Idrees, Matt D. Johansen, Alen Faiz, Peter A. Wark, Philip M. Hansbro, Ian M. Adcock, Gaetano Caramori, Cristiana Stellato

Summary: AU-rich-element factor-1 (AUF-1), an RNA-binding protein, is involved in posttranscriptional regulation of genes related to inflammation and cellular senescence, both of which are pathogenic mechanisms in chronic obstructive pulmonary disease (COPD). Decreased expression of AUF-1 is observed in bronchiolar epithelium of COPD patients and in human airway epithelial cells exposed to cytokines and cigarette smoke. This study identifies AUF-1-targeted transcripts and demonstrates its association with inflammation and senescence-related pathways in COPD.

FRONTIERS IN IMMUNOLOGY (2023)

Article Allergy

Genetic differences according to onset age and lung function in asthma: A cluster analysis

Han-Kyul Kim, Ji-One Kang, Ji Eun Lim, Tae-Woong Ha, Hae Un Jung, Won Jun Lee, Dong Jun Kim, Eun Ju Baek, Ian M. M. Adcock, Kian Fan Chung, Tae-Bum Kim, Bermseok Oh

Summary: Using the UK Biobank dataset, we identified four distinct asthma subtypes based on onset age and lung function. Our study revealed that early onset asthma with reduced lung function had the highest genetic predisposition. Furthermore, clusters with reduced lung function were genetically distinct from clusters with normal lung function.

CLINICAL AND TRANSLATIONAL ALLERGY (2023)

暂无数据